485 related articles for article (PubMed ID: 28606013)
1. Decrease of CD69 levels on TCR Vα7.2
Yong YK; Tan HY; Saeidi A; Rosmawati M; Atiya N; Ansari AW; Rajarajeswaran J; Vadivelu J; Velu V; Larsson M; Shankar EM
Innate Immun; 2017 Jul; 23(5):459-467. PubMed ID: 28606013
[TBL] [Abstract][Full Text] [Related]
2. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161
Yong YK; Saeidi A; Tan HY; Rosmawati M; Enström PF; Batran RA; Vasuki V; Chattopadhyay I; Murugesan A; Vignesh R; Kamarulzaman A; Rajarajeswaran J; Ansari AW; Vadivelu J; Ussher JE; Velu V; Larsson M; Shankar EM
Front Immunol; 2018; 9():472. PubMed ID: 29616020
[TBL] [Abstract][Full Text] [Related]
3. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
Zhou Y; Zhang H; Li Y
Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
[TBL] [Abstract][Full Text] [Related]
4. The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161
Meggyes M; Szanto J; Lajko A; Farkas B; Varnagy A; Tamas P; Hantosi E; Miko E; Szereday L
Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29265516
[TBL] [Abstract][Full Text] [Related]
5. Chronic Viral Infection Compromises the Quality of Circulating Mucosal-Associated Invariant T Cells and Follicular T Helper Cells via Expression of Inhibitory Receptors.
Vimali J; Yong YK; Murugesan A; Tan HY; Zhang Y; Ashwin R; Raju S; Balakrishnan P; Larsson M; Velu V; Shankar EM
Front Biosci (Landmark Ed); 2024 Mar; 29(3):128. PubMed ID: 38538288
[TBL] [Abstract][Full Text] [Related]
6. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
[TBL] [Abstract][Full Text] [Related]
7. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B.
Ratnam DT; Sievert W; Visvanathan K
Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793
[TBL] [Abstract][Full Text] [Related]
9. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
[TBL] [Abstract][Full Text] [Related]
10. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
13. CD8
Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
[TBL] [Abstract][Full Text] [Related]
14. Human intrahepatic CD69 + CD8+ T cells have a tissue resident memory T cell phenotype with reduced cytolytic capacity.
Stelma F; de Niet A; Sinnige MJ; van Dort KA; van Gisbergen KPJM; Verheij J; van Leeuwen EMM; Kootstra NA; Reesink HW
Sci Rep; 2017 Jul; 7(1):6172. PubMed ID: 28733665
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
16. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
17. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
Nan XP; Zhang Y; Yu HT; Li Y; Sun RL; Wang JP; Bai XF
Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403
[TBL] [Abstract][Full Text] [Related]
18. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
[TBL] [Abstract][Full Text] [Related]
19. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of Listeria monocytogenes infection on cytokine production and cytotoxicity of CD8 T cells.
Maruyama S; Shen H; Kanoh M; Matsumoto A; Asano Y
Microbiol Immunol; 2007; 51(9):893-901. PubMed ID: 17895607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]